Literature DB >> 26037393

Evaluation of differences in carotid intima-media thickness in patients affected by systemic rheumatic diseases.

Marco Matteo Ciccone1, Pietro Scicchitano2, Annapaola Zito2, Francesca Cortese2, Cinzia Rotondo3, Laura Coladonato3, Michele Gesualdo2, Antonella Notarnicola3, Florenzo Iannone3.   

Abstract

The objective of this study is to investigate whether rheumatic autoimmune diseases, systemic sclerosis (SSc) in particular, are associated with increased carotid intima-media thickness (C-IMT). A total of 108 clinical outpatients (93 females), mean age 51 ± 14 years suffering from CTD were consecutively enrolled. Patients were subdivided into the following two groups: (1) Systemic Sclerosis (SSc, 60 patients); (2) non-Systemic Sclerosis (NoSSc, 48 patients). No randomization was managed. All patients underwent structured clinical interview, physical examination, laboratory evaluation and two-dimensional echo-color Doppler of the carotid arteries to measure C-IMT and atherosclerotic plaques. Framingham risk score was also calculated. We also enrolled 108 healthy controls (HC), matched by sex and age. The primary outcome was to stratify cardiovascular risk of CTD patients. There were no significant differences between SSc and NoSSc patients regarding any of the demographics and traditional cardiovascular risk factors. Mean C-IMT was not significantly different between the whole CTD patients (0.86 ± 0.13 mm) and HC (0.83 ± 0.13 mm). C-IMT was significantly higher in SSc than in NoSSc group (0.91 ± 0.1 mm vs 0.80 ± 0.14 mm, p < 0.001). Furthermore, C-IMT in SSc group was significantly higher than C-IMT in controls (0.91 ± 0.1 mm vs 0.83 ± 0.13 mm, p < 0.001). C-IMT did correlate neither with disease activity nor with drug intake. SSc patients had a significant increase in C-IMT as compared to NoSSc patients and healthy controls.

Entities:  

Keywords:  Cardiovascular risk; Carotid intima-media thickness; Systemic rheumatic diseases; Systemic sclerosis

Mesh:

Year:  2015        PMID: 26037393     DOI: 10.1007/s11739-015-1250-4

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN: 1828-0447            Impact factor:   3.397


  41 in total

Review 1.  Polymyositis and dermatomyositis (first of two parts).

Authors:  A Bohan; J B Peter
Journal:  N Engl J Med       Date:  1975-02-13       Impact factor: 91.245

Review 2.  Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group.

Authors:  C Vitali; S Bombardieri; R Jonsson; H M Moutsopoulos; E L Alexander; S E Carsons; T E Daniels; P C Fox; R I Fox; S S Kassan; S R Pillemer; N Talal; M H Weisman
Journal:  Ann Rheum Dis       Date:  2002-06       Impact factor: 19.103

3.  Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.

Authors: 
Journal:  Circulation       Date:  2002-12-17       Impact factor: 29.690

Review 4.  Premature atherosclerotic disease in systemic lupus erythematosus--role of inflammatory mechanisms.

Authors:  Elisa Y Rhew; Rosalind Ramsey-Goldman
Journal:  Autoimmun Rev       Date:  2005-09-06       Impact factor: 9.754

Review 5.  The laboratory approach to the diagnosis of autoimmune diseases: is it time to change?

Authors:  Danilo Villalta; Renato Tozzoli; Elio Tonutti; Nicola Bizzaro
Journal:  Autoimmun Rev       Date:  2007-02-07       Impact factor: 9.754

6.  A stepwise approach to assess the impact of clustering cardiometabolic risk factors on carotid intima-media thickness: the metabolic syndrome no-more-than-additive.

Authors:  Gian Paolo Fadini; Anna Coracina; Sandro Inchiostro; Antonio Tiengo; Angelo Avogaro; Saula Vigili de Kreutzenberg
Journal:  Eur J Cardiovasc Prev Rehabil       Date:  2008-04

7.  Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus.

Authors:  M C Hochberg
Journal:  Arthritis Rheum       Date:  1997-09

8.  Silent cardiovascular involvement in patients with diffuse systemic sclerosis: a controlled cross-sectional study.

Authors:  Maurizio Turiel; Luigi Gianturco; Cristian Ricci; Piercarlo Sarzi-Puttini; Livio Tomasoni; Vito de Gennaro Colonna; Paolo Ferrario; Oscar Epis; Fabiola Atzeni
Journal:  Arthritis Care Res (Hoboken)       Date:  2013-02       Impact factor: 4.794

Review 9.  Scleroderma: from cell and molecular mechanisms to disease models.

Authors:  David J Abraham; John Varga
Journal:  Trends Immunol       Date:  2005-09-15       Impact factor: 16.687

Review 10.  Rheumatic disease and carotid intima-media thickness: a systematic review and meta-analysis.

Authors:  Pascal N Tyrrell; Joseph Beyene; Brian M Feldman; Brian W McCrindle; Earl D Silverman; Timothy J Bradley
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-02-11       Impact factor: 8.311

View more
  2 in total

1.  Peripheral Microangiopathy Changes in Pulmonary Arterial Hypertension Related to Systemic Sclerosis: Data From a Multicenter Observational Study.

Authors:  Dilia Giuggioli; Valeria Riccieri; Edoardo Cipolletta; Nicoletta Del Papa; Francesca Ingegnoli; Amelia Spinella; Greta Pellegrino; Anna Maria Risa; Marco de Pinto; Silvia Papa; Giuseppe Armentaro; Rossella De Angelis
Journal:  Front Cardiovasc Med       Date:  2022-07-11

2.  Significant Associations of Neurological Complications of Herpes Zoster With Stroke in Rheumatoid Arthritis Patients.

Authors:  Tsai-Ling Liao; Ching-Heng Lin; Hsin-Hua Chen; Yi-Ming Chen; Che-Chen Lin; Der-Yuan Chen
Journal:  J Am Heart Assoc       Date:  2017-07-19       Impact factor: 5.501

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.